As of Apr 17
| +0.02 / +0.29%|
The 1 analysts offering 12-month price forecasts for Cumberland Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a -21.32% decrease from the last price of 6.99.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.